Abstract
We propose a chelation-assisted assembly of multidentate CNs into metal-organic nanoparticles (MONs). Multidentate CNs functionalized with coordination sites participate equally as organic linkers in MON construction, which is driven by chelation between metal ions and coordination sites. MONs assembled from Au nanoparticles display particle number- and size-dependent optical properties. In addition, the resulting CN-assembled MONs give evidence that assembly was dictated by the multidentate surface ligand rather than the size, shape or material of CNs. With this chelation-assisted strategy, it is possible to control the number of assembled CNs and build the connections between them.
Colloidal nanoparticles (CNs), also called ‘artificial atoms’, display unique physical and chemical properties owing to the nanoscale size effect, as well as significant collective properties upon assembly.1–2 Assembly of CNs has been demonstrated to be a powerful tool to control the structure and properties of assembled nanoparticles for potential applications in, for example, catalysis, electrical devices, and biochemical sensors.3–4 New optical, electronic, and magnetic properties can be obtained as a result of interactions between closely packed individual nanoparticles.2,5 Assembly of CNs can be governed by striking a balance among various forces such as van der Waals forces, hydrogen bonding and dipole interactions.2,6 The assembly process can also be assisted by use of a template to generate electrical or magnetic fields.7–8 Various structures, including 1D chains,9–11 2D sheets,12 3D crystals,13–15 and 3D superparticles have been produced.16 Several approaches including polymerization,10,17 DNA templates,3,18 or oil-in-water microemulsions19–20 have been developed to trigger the assembly of CNs. However, despite recent successes, precise control over the assembly of CNs remains a challenge.
Metal-organic nanoparticles (MONs), constructed of metal ions and organic linkers with multiple coordination sites, have been explored for various applications, including drug delivery, optoelectronics, and chemical sensing.21–23 The structure of MONs strongly depends on the coordination geometry of the metal ions, as well as the conformation, and coordination sites of the organic linkers. An important research goal is to fabricate MONs with novel composition to obtain interesting properties for new applications.24 Mirkin et al. reported a class of metal-metalloligand particles which further enabled preparation of fluorescent MONs capable of storing hydrogen.22,24,25 Inspired by the chelation of metal ions and organic linkers, we herein propose that multidentate inorganic CNs with coordination sites can be assembled into MONs via chelation between metal ions and coordination sites on organic linkers and CNs.
Considering our extensive experience in the design and synthesis of nanoarchitectures, we proposed that the thermal annealing of Zn2+ ions and Mn(III) meso-tetra (4-carboxyphenyl) porphine chloride (Mn-TCPP), which has four carboxylic acid coordination sites, would generate Zn-Mn-coordinated MONs (ZnMONs) in the presence of pyrazine and polyvinylpyrrolidone (PVP). Moreover, we reason that multidentate colloidal nanoparticles (Scheme 1) of different elements and functionalized with coordination sites could be incorporated into ZnMONs. To form the initial ZnMONs, a solution of Mn-TCPP in DMF/ethanol mixed solvent was added to another solution of Zn(NO3)2, pyrazine and PVP, also in DMF/ethanol. The resulting solution was then incubated in an oil bath at 80 °C for 24 hours. ZnMONs assembled with CNs were synthesized in a similar way, but multidentate CNs with carboxylate ligands (or capped with carboxylic acid-containing ligands after ligand exchange)26 were introduced into the initial ZnMON mother solution and then incubated in an oil bath at 80 °C for 24 hours. The ZnMONs or CN-assembled ZnMONs were washed with ethanol and finally redispersed in ethanol.
The colloidal NPs and ZnMONs were characterized with transmission electron microscopy (TEM) (Fig. 1a, Fig. S1), powder X-ray diffraction (Fig. S2-S4) dynamic light scattering (DLS) (Fig. S5-S7), UV/Vis (Fig. S8), IR spectroscopy (Fig. S9) and X-ray photoelectron spectroscopy (XPS) (Fig. 1g and Fig. S10). Fig. 1a shows that ZnMONs are spherical with an average diameter of 120 ± 14 nm, while DLS measurement exhibited an average hydrodynamic diameter of 140 nm. According to UV/Vis spectra, an obvious change was observed in the Soret band (380–500 nm) of ZnMONs compared to Mn-TCPP. In addition, a red shift of Q band (500–750 nm) was observed and may be attributed to the assembly of Mn-TCPP upon chelation with zinc ions.27 Infrared (IR) spectrum of Zn-MONs displayed characteristic peaks of alkane (C-H at 2930 cm−1) and amide (C=O at 1660 cm−1) from PVP, as well as aromatic C=C (1605 cm−1) signals from Mn-TCPP (Fig. S9). As a consequence of the overlap of the peaks for pyrazine and Mn-TCPP at 1630 cm−1 and 1400 cm−1, it was not possible to determine from the IR spectra whether pyrazine participated in the construction of ZnMONs. Therefore, a control experiment involving ZnMON synthesis was carried out in the absence of pyrazine. However, no uniform ZnMONs were formed without pyrazine.
To incorporate multidentate CNs into the ZnMONs, we first synthesized aqueous Au nanoparticles (15 ± 1 nm) containing citrate as capping ligands. Aqueous Au nanoparticles (Au15) were concentrated by centrifugation and then redispersed in DMF. The concentrated Au nanoparticles were then added to the Zn2+/PVP/pyrazine solution in DMF/ethanol prior to introducing Mn-TCPP. After incubation in an oil bath for 24 hours, uniform Au15-ZnMON core-shell structures were observed, as shown in the TEM images (Fig. 1b). We further studied the effect of Au-CN size on the assembly. Aqueous Au nanoparticles with different sizes and shapes (i.e., 25 nm spheres (Au25), 50 nm spheres (Au50) and nanorods 10 × 41 nm (AuNR)), but with the same citrate capping ligands, were used in the synthesis. TEM images demonstrate that all Au nanoparticles gave rise to uniform core-shell structures (Au15-ZnMON (Fig. 1b), Au25-ZnMON (Fig. 1c), Au50-ZnMON (Fig. 1d), and AuNR-MON (Fig. 1e)). Diameter and shell thickness are listed in Table 1. In addition, the size and shape of AuCNs did not affect the assembly of CNs. However, CN- assembled ZnMON was not observed when Au nanorods with same size and shape, but cetyltrimethylammonium bromide (CTAB) as capping ligand, were introduced to the ZnMON mother solution (Fig. 1f). This is because CTAB is incapable of chelating with Zn2+ as carboxylate, although CTAB-capped Au nanorods are aqueous and can be redispersed in DMF.
Table 1.
Diameter (nm) | Shell thickness (nm) | |
---|---|---|
Au15-ZnMON | 105 ± 5 | 44 ± 3 |
Au25-ZnMON | 103 ± 3 | 38 ± 2 |
Au50-ZnMON | 124 ± 4 | 35 ± 2 |
AuNR-ZnMON | 90 (±4) × 66 (±4) | 22 ± 3 |
UV-vis absorption spectra of the Au nanoparticles, ZnMONs and AuNC-ZnMONs are shown in Fig. 2. No obvious difference was observed between ZnMONs and Au15-ZnMONs (Fig. 2a) indicating that the shell is also amorphous and assembled from metal ions and organic linkers with multi-coordination sites through coordination between Zn ions and carboxylic acid groups. As the sizes of Au nanoparticles increased, the surface plasmon peak at about 525 nm contributed more to the AuNC-ZnMON spectrum, resulting in a slight red shift (Fig.s 2b, 2c). For AuNRs (Fig. 2d), the surface plasmon band appears at about 800 nm, and the red shift in AuNR-ZnMONs is only 8 nm. These two red shifts are attributed to the intrinsic size effect of Au nanoparticles and an increase in the local refractive index around the Au nanoparticles.28–30 However, the Soret band and the Q band of ZnMONs did not move at all after being assembled with Au nanoparticles, indicating that the incorporation of Au nanoparticles into ZnMONs did not affect the structure of ZnMONs. Fig. 3 shows the EDS line scan of Au15-ZnMONs, which confirms the chemical assignments and component segregation. Au nanoparticles as core show independent peaks (blue), whereas Mn (red) and Zn (green) are evenly distributed in ZnMONs.
Having demonstrated that citrate-modified multidentate Au nanoparticles can be assembled into ZnMONs by complexation with Zn2+ ions, we further extended the scope of the method with multidentate iron oxide and upconversion nanoparticles (UCNP), which were functionalized with 3,4-dihydroxyhydrocinnamic acid by ligand exchange. As shown in the TEM images, hexagonal UCNP and iron oxide can be incorporated into ZnMONs (Fig. 4b and 4c). Original properties can arise from synergistic effects between the core and the shell of the particles. Singlet oxygen generation from the synergistic effect of UCNP/MON core shell structures was studied Due to spectra overlap of the emission of UCNP and absorption of Mn-TCPP from 510 nm to 560 nm, when UCNP was irradiated with 980 nm light, the photosensitizer Mn-TCPP would be excited by the emission of UCNP and generate singlet oxygen which can be potentially used for further photodynamic therapy (PDT). Singlet oxygen generation was monitored by SOSG as shown in fig. S11. The successful assembly of UCNP and iron oxide nanoparticles into ZnMONs indicates that it is the surface capping ligand (carboxylate), rather than the material itself, that dictates assembly.
Since each multidentate nanoparticle has equal opportunity to be assembled into ZnMONs, we assumed that the number of multidentate colloidal nanoparticles assembled into ZnMONs would be concentration-dependent. To elucidate this hypothesis, different concentrations of Au and iron oxide nanoparticles were used for assembly. As expected, more colloidal nanoparticles were assembled into ZnMONs as the concentration of CNs increased. In the case of Au15-ZnMON-1, 70% of ZnMONs each hold one Au15 nanoparticle and 18% of ZnMONs each hold two Au15 nanoparticles, while ZnMONs with three or more Au nanoparticles account for 6%. However, when six-fold of Au15 nanoparticles were added, as in the case of Au15-ZnMON-2, the ratio of ZnMONs holding two Au15 nanoparticles increased to 26% and ZnMONs with three or more Au nanoparticles increased to 42% (Fig. 5a and Fig. S12). A broad peak appeared around 560 nm after red shift confirmed the assembly of ZnMONs with 3 and above Au-15 nanoparticles (Fig. 5b).31 Unfortunately, assembly was not successful when an excess of multidentate CNs was added, because Mn-TCPP and Zn ions would be limiting reagents. Similarly, we also observed an increase in the number of nanoparticles assembled into ZnMONs with increased concentration of multidentate iron oxide nanoparticles, as shown in Fig. 5c and 5d (Iron oxide11-ZnMON-1), 5e and 5f (Iron oxide11-ZnMON-2), and 5g and 5h (Iron oxide11-ZnMON-3). Therefore, the number of colloidal nanoparticles assembled into ZnMONs is concentration-dependent. Additionally, magnetic property variation of iron oxide/MON with different concentration of assembled iron oxide nanoparticles is revealed by the magnetization measurement. As shown in Fig. S13, all three samples demonstrated the typical superparamagnetic behavior, since neither remanent magnetization nor coercivity was detected.
Conclusions
In conclusion, we have developed a new chelation-assisted procedure to incorporate multidentate CNs into ZnMONs. The concentration of multidentate CNs allows for control over the number of CNs in ZnMONs. This assembly methodology is applicable to a library of colloidal nanoparticles with photoelectrochemical properties, such as semiconductor quantum dots and metal nanoparticles, as long as their multidentate surfaces are well developed. The incorporating multidentate CNs into ZnMONs by complexation will also open up many new opportunities for practical applications in biochemical and electrical areas.
Supplementary Material
Acknowledgements
The The authors are grateful to Dr. Kathryn Williams for her critical comments during the preparation of this manuscript. This work is supported by grants awarded by the National Institutes of Health (GM079359 and CA133086) and the National science foundation under the Division of Materials Research, Grant number DMR-1305783. It is also supported by grants awarded by the National Key Scientific Program of China (2011CB911000 and 2013CB933701), the Foundation for Innovative Research Groups of NSFC (Grant 21221003 and NSFC 21327009).
Footnotes
Conflicts of interest
There are no conflicts to declare.
Electronic Supplementary Information (ESI) available: [details of any supplementary information available should be included here]. See DOI: 10.1039/x0xx00000x
Notes and references
- 1.Macfarlane RJ, Lee B, Jones MR, Harris N, Schatz GC, Mirkin CA, Science, 2011. 334, 204–208. [DOI] [PubMed] [Google Scholar]
- 2.Nie Z, Petukhova A, Kumacheva E, Nat. Nanotech, 2010. 5, 15–25. [DOI] [PubMed] [Google Scholar]
- 3.(a) Sun Z, Sun B, Qiao M, Wei J, Yue Q, Wang C, Deng Y, Kaliaguine S, Zhao D, J. Am. Chem. Soc 2012, 134, 17653–17660. [DOI] [PubMed] [Google Scholar]; (b) Jone MR, Seeman NC, Mirkin CA, Science, 2015, 347, 1260901. [DOI] [PubMed] [Google Scholar]
- 4.Chen O, Riedemann L, Etoc F, Herrmann H, Coppey M, Barch M, Farrar CT, Zhao J, Bruns OT, Wei H, Guo P, Cui J, Jensen R, Chen Y, Harris DK, Cordero JM, Wang Z, Jasanoff A, Fukumura D, Reimer R, Dahan M, Jain RK, Bawendi MG, Nat. Commun, 2014, 5, 5093–5100. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Kuzyk A, Schreiber R, Fan Z, Pardatscher G, Roller E, Hogele A, Simmel FC, Govorov AO, Liedl T, Nature, 2012, 483, 311–314. [DOI] [PubMed] [Google Scholar]
- 6.Zeng C, Chen Y, Kirschbaum K, Lambright KJ, Jin R, Science, 2016, 354, 1580–1584. [DOI] [PubMed] [Google Scholar]
- 7.Bishop KJM, Wilmer CE, Soh S, Grzybowski BA, Small, 2009, 5, 1600–1630. [DOI] [PubMed] [Google Scholar]
- 8.Lalatonne Y, Richardi J, Pileni MP, Nat. Mater, 2004, 3, 121–125. [DOI] [PubMed] [Google Scholar]
- 9.Shen X, Chen L, Li D, Zhu L, Wang H, Liu C, Wang Y, Xiong Q, Chen H, ACS Nano, 2011, 5, 8426–8433. [DOI] [PubMed] [Google Scholar]
- 10.Nie Z, Fava D, Kumacheva E, Zou S, Walker GC, Rubinstein M, Nat. Mater, 2007, 6, 609–614. [DOI] [PubMed] [Google Scholar]
- 11.Kim PY, Oh J, Nam J, J. Am. Chem. Soc, 2015, 137, 8030–8033. [DOI] [PubMed] [Google Scholar]
- 12.Tang Z, Zhang Z, Wang Y, Glotzer SC, Kotov NA, Science, 2006, 314, 274–278. [DOI] [PubMed] [Google Scholar]
- 13.Zhang J, Santos PJ, Gabrys PA, Lee S, Liu C, Macfarlane RJ, J. Am. Chem. Soc, 2016, 138, 16228–16231. [DOI] [PubMed] [Google Scholar]
- 14.Henzie J, Grünwald M, Widmer-Cooper A, Geissler PL, Yang P, Nat. Mater, 2011, 11, 131–137. [DOI] [PubMed] [Google Scholar]
- 15.Talapin DV, Shevchenko EV, Bodnarchuk MI, Ye X, Chen J, Murray CB, Nature, 2009, 461, 964–967. [DOI] [PubMed] [Google Scholar]
- 16.Wang T, Zhuang J, Lynch J, Chen O, Wang Z, Wang X, LaMontagne D, Wu H, Wang Z, Cao YC, Science, 2012, 338, 358–363. [DOI] [PubMed] [Google Scholar]
- 17.Liu K, Nie Z, Zhao N, Li W, Rubinstein M, Kumacheva E, Science, 2010, 329, 197–200. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Roger WB, Shih WM, Manoharan VN, Nat. Rev. Mater, 2016, 1, 16008–16021. [Google Scholar]
- 19.Wang T, LaMontagne D, Lynch J, Zhuang J, Cao YC, Chem. Soc. Rev, 2013, 42, 2804–2823. [DOI] [PubMed] [Google Scholar]
- 20.Boles MA, Engel M, Talapin DV, Chem. Rev, 2016, 116, 11220–11289. [DOI] [PubMed] [Google Scholar]
- 21.Carné A, Carbonell C, Imaz I, Maspoch D, Chem. Soc. Rev, 2011, 40, 291–305. [DOI] [PubMed] [Google Scholar]
- 22.Oh M, Mirkin CA, Nature, 2005, 438, 651–654. [DOI] [PubMed] [Google Scholar]
- 23.Sun X, Dong S, Wang E, J. Am. Chem. Soc, 2005, 127, 13102–13103. [DOI] [PubMed] [Google Scholar]
- 24.Oh M, Mirkin CA, Angew. Chem. Int. Ed, 2006, 45, 5492–5494. [DOI] [PubMed] [Google Scholar]
- 25.Jeon Y, Armatas GS, Heo J, Kanatzidis MG, Mirkin CA, Adv. Mater, 2008, 20, 2105–2110. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Liu Y, Purich DL, Wu C, Wu Y, Chen T, Cui C, Zhang L, Cansiz S, Hou W, Wang Y, Yang S, Tan W, J. Am. Chem. Soc, 2015, 137, 14952–14958. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Zhao M, Wang Y, Ma Q, Huang Y, Zhang X, Ping J, Zhang Z, Lu Q, Yu Y, Xu H, Zhao Y, Zhang H, Adv. Mater, 2015, 27, 7372–7378. [DOI] [PubMed] [Google Scholar]
- 28.Ghosh SK, Pal T, Chem. Rev, 2007, 107, 4797–4862. [DOI] [PubMed] [Google Scholar]
- 29.Piliarik M, Kvasnička P, Galler N, Krenn JR, Homola J, Opt J. Express, 2011, 19, 9213–9220. [DOI] [PubMed] [Google Scholar]
- 30.Kang H, Trondoli AC, Zhu G, Chen Y, Chang Y, Liu H, Huang Y, Zhang X, Tan W, ACS Nano, 2011, 5, 5094–5099. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Urban AS, Shen X, Wang Y, Large N, Wang H, Knight MW, Nordlander P, Chen H, Halas NJ, Nano Lett, 2013, 13, 4399–4403. [DOI] [PubMed] [Google Scholar]
- 32.Grabar KC, Freeman RG, Hommer MB, Natan MJ, Anal. Chem, 1995, 67, 735–743. [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.